Article Text

Download PDFPDF
Treatment of a case of feline baclofen toxicosis with intravenous lipid therapy
  1. Paul Edwards1,
  2. Nadia Shihab2 and
  3. Harry W. Scott2
  1. 1Abington Park Veterinary Group, 427 Wellingborough Road, Northampton NN1 4EZ, UK
  2. 2Southern Counties Veterinary Specialists, Unit 6 Forest Corner Farm, Hangersley, Ringwood, Hampshire BH24 3JW, UK
  1. Correspondence to
    Paul Edwards, pedwards{at}


Baclofen (γ-amino-β-[p-chlorophenyl]-butyric acid) is a centrally acting skeletal muscle relaxant that is frequently used in people. Baclofen toxicosis has previously been successfully treated in cats via supportive therapy alone, whereas administration of an intravenous lipid emulsion (ILE) has been reported as an adjunct to supportive therapy in dogs with baclofen toxicosis. This case report presents a cat that became severely stuporous following ingestion of baclofen (10 mg/kg) and was successfully treated with administration of ILE without any apparent side effects. The cat received a 1.5 ml/kg bolus of a 20 per cent lipid emulsion intravenously followed by a constant rate infusion (CRI) of 15 ml/kg/hour. Approximately one hour following initiation of the CRI, the cat became acutely more responsive. Intravenous lipid therapy may be a useful adjunct to conventional treatment in cases of feline baclofen toxicosis and other lipophilic drug toxicoses.

  • Baclofen
  • Toxicosis
  • Lipid Emulsion
  • Lipid Sink
View Full Text

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.